The funds will be used to help the company expand into the employer and health plan markets and speed up the development of its AI technology for providers and members.
The company began trading on the NYSE today under the ticker symbol HNGE, opening at $39.25, up 23% from its IPO price of $32, and closing at $37.56 per share.
The funds will be used to support building a GMP system for long-acting injectables and grow the company's robotic lab.
MobiHealthNews examines the impact of automated dispensing cabinets, robotic surgery, AI in radiology and smart screens on patients' receiving and physicians' delivering care.
Layer Health's AI platform will be used to automate reporting and accelerate the chart review process.
MedGemma, built on Gemma 3, aims to help developers build AI-based healthcare applications with open models, including multimodal and text-only versions.
The AI-powered COPD care coordination tool uses EHR data and natural language processing to identify and manage high-risk patients.
The platform will be offered via the firm's Venture Studio, which helps healthcare startups gain commercial traction, connect with target buyers and form partnerships with health systems.
AI-powered value-based behavioral health company Ontrak and generative AI radiology workflow company Rad AI also garnered investments.
